Clinical Trial Update: Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing whether adding erlotinib to cisplatin-based radiation improves outcomes in stage III/IV head and neck squamous cell carcinoma; results h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Platinol (cisplatin)
• Tarceva (erlotinib)

Snippet

Sponsor: University of Washington | Conditions: Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx | Phase 2 | Status: COMPLETED | Results posted: 2013-04-02